Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.73
+0.00500.29%
Volume:381.49K
Turnover:659.09K
Market Cap:73.38M
PE:-0.96
High:1.78
Open:1.78
Low:1.70
Close:1.72
52wk High:5.50
52wk Low:1.54
Shares:42.54M
Float Shares:35.32M
Volume Ratio:0.91
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-17.25
PE(LYR):-1.23

Loading ...

Annovis Bio wins U.S. patent for buntanetap to treat brain infection-related injuries

Reuters
·
Apr 02

Annovis Publishes Historical Review of Buntanetap in The Scientist

GlobeNewswire
·
Mar 31

Annovis Bio Inc - CEO Maria Maccecchini to Serve as Acting CFO Until Replacement Is Identified - SEC Filing

THOMSON REUTERS
·
Mar 26

Annovis Bio Inc - Mark Guerin Steps Down as CFO Effective March 23, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 26

Annovis Bio CFO Mark Guerin departs; CEO Maria Maccecchini becomes acting CFO effective March 23, 2026

Reuters
·
Mar 26

Annovis Bio enters partnership with NeuroRPM

TIPRANKS
·
Mar 19

Annovis Bio partners with NeuroRPM for AI wearable monitoring in Parkinson’s trial

Reuters
·
Mar 19

Annovis Bio partners with NeuroRPM to deploy FDA-cleared AI digital biomarkers in Parkinson’s study

Reuters
·
Mar 19

Neurorpm to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial

THOMSON REUTERS
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY) and Annovis Bio (ANVS)

TIPRANKS
·
Mar 19

BRIEF-Annovis Provides Corporate Updates And Reports Fiscal Year 2025 Financial Results

Reuters
·
Mar 16

Annovis Bio reports FY25 EPS ($1.40) vs. ($2.31) last year

TIPRANKS
·
Mar 16

Annovis Bio Q4 EPS $(0.39) Misses $(0.34) Estimate

Benzinga Earnings
·
Mar 16

Annovis Bio Inc: Estimates That Its Current Cash and Cash Equivalents Will Enable It to Fund Its Operations Into Q3 of 2026

THOMSON REUTERS
·
Mar 16

Press Release: Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

Dow Jones
·
Mar 16

Annovis Bio FY 2025 net loss widens 17% to USD 28.86 million, interest income rises 111% to USD 0.7 million

Reuters
·
Mar 14

Annovis Bio to Present Twice at AD/PD 2026 International Conference

Reuters
·
Mar 03